基本信息
浏览量:508
职业迁徙
个人简介
I oversees the clinical trial offerings for gastrointestinal (GI) cancers across the Sarah Cannon network and works closely with partners on clinical trial design. My work in early drug development has helped guide first-in-man agents through proof-of-concept studies. In my new role, I will continue to work in drug development and lead Sarah Cannon’s GI cancer research efforts.
As Chief Development Officer, I will work closely with the leaders of Sarah Cannon Development Innovations, the organization’s CRO, and clinical operations teams to provide additional, experienced physician leadership to these lines of business.
As Chief Development Officer, I will work closely with the leaders of Sarah Cannon Development Innovations, the organization’s CRO, and clinical operations teams to provide additional, experienced physician leadership to these lines of business.
研究兴趣
论文共 666 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Robin M.J.M. van Geel,Josep Tabernero,Elena Elez,Johanna C. Bendell,Anna Spreafico,Martin Schuler,Takayuki Yoshino,Jean-Pierre Delord,Yasuhide Yamada,Martijn P. Lolkema, Jason E. Faris,Ferry A.L.M. Eskens,
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
CANCER IMMUNOLOGY IMMUNOTHERAPYno. 7 (2023): 2443-2458
Geoffrey I. Shapiro, Katherine M. Bell‐McGuinn,Julian R. Molina,Johanna C. Bendell,James Spicer,Eunice L. Kwak, Susan S. Pandya, Robert Millham, Gary Borzillo,Kristen J. Pierce, Lin‐Hai Han,Brett E. Houk,
openalex(2023)
Cláudia S Ferreira,Galina Babitzki,Irina Klaman,Oliver Krieter,Katharina Lechner,Johanna Bendell, Suzana Vega Harring,Florian Heil
Frontiers in oncology (2023): 1157596-1157596
openalex(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn